A formulation containing Cymbopogon flexuosus essential oil: improvement of biochemical parameters and oxidative stress in diabetic rats

• Ailton Santos Sena-Júnior,
• Cleverton Nascimento Santana Andrade,
• Pedro Henrique Macedo Moura,
• Jocsã Hémany Cândido dos Santos,
• Cauãn Torres Trancoso,
• Eloia Emanuelly Dias Silva,
• Deise Maria Rego Rodrigues Silva,
• Ênio Pereira Telles,
• Luiz André Santos Silva,
• Isabella Lima Dantas Teles,
• Sara Fernanda Mota de Almeida,
• Daniel Alves de Souza,
• Jileno Ferreira Santos,
• Felipe José Aidar Martins,
• Ana Mara de Oliveira e Silva,
• Sandra Lauton-Santos,
• Guilherme Rodolfo Souza de Araujo,
• Cristiane Bani Correa,
• Rogéria De Souza Nunes,
• Lysandro Pinto Borges and
• Ana Amélia Moreira Lira

Beilstein J. Nanotechnol. 2025, 16, 617–636, doi:10.3762/bjnano.16.48

• cytoplasmic vesicles, indicating dysfunction in metabolization and impaired cell metabolism. This finding, associated with necrosis and inflammation, suggests an exacerbated cellular response to an aggressive agent, leading to structural collapse of the liver tissue. These histopathological changes indicate

• one of the most obvious findings, characterized by the accumulation of cytoplasmic vesicles, a phenomenon often associated with degenerative and apoptotic processes. This alteration reflects an impairment of cellular homeostasis and represents an important marker of liver damage in various

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy

• Shiwani Randhawa,
• Trilok Chand Saini,
• Manik Bathla,
• Rahul Bhardwaj,
• Rubina Dhiman and
• Amitabha Acharya

Beilstein J. Nanotechnol. 2025, 16, 561–580, doi:10.3762/bjnano.16.44

• nanobiomaterials derived from cell primitives as a promising therapeutic strategy. These biomimetic nanomaterials, comprising components such as cells, extracellular vesicles (EVs), and cell membranes offer several advantages. Their nanoparticulate size facilitates long-term circulation, reduces immune response

Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

• endocytosis enables cellular entry, achieving efficient release and nuclear delivery of ASOs remains a challenge as a consequence of potential sequestration and degradation within endocytic vesicles [79][80]. This issue is prevalent in the majority of therapeutic delivery systems that enter via endocytosis

Recent advances in photothermal nanomaterials for ophthalmic applications

• Jiayuan Zhuang,
• Linhui Jia,
• Chenghao Li,
• Rui Yang,
• Jiapeng Wang,
• Wen-an Wang,
• Heng Zhou and
• Xiangxia Luo

Beilstein J. Nanotechnol. 2025, 16, 195–215, doi:10.3762/bjnano.16.16

• , over time, the excessive proliferation of conjunctival fibroblasts and remodeling of collagen around the vesicles can lead to the failure of the surgical effects [144]. The primary strategy to counter fibrosis has been the use of antimetabolic drugs, but this often leads to complications like filter

• thermally destroys conjunctival fibroblasts and invasive bacteria around conjunctival vesicles, while the 5-fluorouracil (5-Fu) inhibits fibrous responses in filter vesicles, thus achieving effective IOP reduction [145]. 3.5 Endophthalmitis Endophthalmitis, commonly resulting from pathogenic infections, is

Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

• Naths Grazia Sukubo,
• Paolo Bigini and
• Annalisa Morelli

Beilstein J. Nanotechnol. 2025, 16, 97–118, doi:10.3762/bjnano.16.10

Mechanistic insights into endosomal escape by sodium oleate-modified liposomes

• Ebrahim Sadaqa,
• Satrialdi,
• Fransiska Kurniawan and
• Diky Mudhakir

Beilstein J. Nanotechnol. 2024, 15, 1667–1685, doi:10.3762/bjnano.15.131

• drug delivery has spurred extensive research into liposomal systems. These vesicles, with their inherent ability to encapsulate and protect a diverse range of therapeutic agents, including small molecule drugs, proteins, and genetic material such as DNA and RNA, hold significant promise for

• vesicles. To standardize the size distribution, the sonicated dispersion underwent five cycles of extrusion through a 100 nm polycarbonate membrane using an Avanti Mini-Extruder. The finalized liposomal formations underwent a comprehensive characterization, assessing size, PDI, and zeta potential through

Attempts to preserve and visualize protein corona on the surface of biological nanoparticles in blood serum using photomodification

• Julia E. Poletaeva,
• Anastasiya V. Tupitsyna,
• Alina E. Grigor’eva,
• Ilya S. Dovydenko and
• Elena I. Ryabchikova

Beilstein J. Nanotechnol. 2024, 15, 1654–1666, doi:10.3762/bjnano.15.130

• results showed that a protein corona is present on extracellular vesicles and lipoproteins isolated by UC. The isolation of bio-NPs through sucrose gradient or cushion did not preserve the protein corona. At the same time, we observed signs of a negative effect of the sucrose gradient on bio-NPs of intact

• obtained direct images of a “natural” protein corona on natural bio-NPs of blood serum for the first time Keywords: chylomicrons; extracellular vesicles; lipoproteins; photomodification; protein corona; Introduction The existence of a protein corona on all nanoparticles (NPs) entering biological fluids

• are increasingly interested in studying the protein corona on extracellular vesicles (EVs), mainly exosomes, which play an important role in the transmission of molecular signals in the body. The influence of the protein corona on EVs on their interaction with body cells, including cells of the immune

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• such as: loss of stability, low efficiency in crossing biological barriers, inadequate efficacy in reaching target active molecules, and poor biodistribution [13][14]. Nanocarriers are employed to transport raw materials, which can be vesicles or solid nanoparticles [15]. Despite the significant

• these carriers are improved [19][21][22][23][24][25]. Various cellular components such as extracellular vesicles, leukocyte and red blood cell membranes are beneficial for developing bioinspired devices. Specific targets, including peptides, aptamers, proteins, and viral capsids, may also be utilized in

• -described for nanoparticles, and this process entails three steps: obtaining membrane-derived vesicles from a cellular source (1); generating the nanoparticles (2); and fusing the vesicles with the particles (3) [34][35][36][37]. Obtaining membrane vesicles requires the lysis of donor cells, necessitating

Entry of nanoparticles into cells and tissues: status and challenges

• Kirsten Sandvig,
• Tore Geir Iversen and
• Tore Skotland

Beilstein J. Nanotechnol. 2024, 15, 1017–1029, doi:10.3762/bjnano.15.83

• excretion. Finally, we discuss requirements for bringing NPs into clinical use and aspects when it comes to usage of complex and slowly degraded or nondegradable NPs. Keywords: biodegradable; biodistribution; endocytosis; extracellular vesicles; nanomedicine; nanoparticles; Introduction Nanoparticles (NPs

• types of molecules. It is now common to include vesicles originating from cells as being NPs. During the last decade there has been an amazing increase in studies of exosomes, small vesicles secreted by fusion of multivesicular bodies (late endosomes) with the plasma membrane of cells. Also, release of

• other types of vesicles, for instance from the plasma membrane, may play a role in the transfer of information between cells. For a list of various types of extracellular vesicles (EVs), see [5]. For therapeutic purposes, EVs may not only be loaded with drugs after the release from cells, but incubation

Comparative analysis of the ultrastructure and adhesive secretion pathways of different smooth attachment pads of the stick insect Medauroidea extradentata (Phasmatodea)

• Julian Thomas,
• Stanislav N. Gorb and
• Thies H. Büscher

Beilstein J. Nanotechnol. 2024, 15, 612–630, doi:10.3762/bjnano.15.52

• presence of numerous vesicles (ve), which can be distinguished as either black when stained with toluidine blue and Cason or show an orange colour without staining (Figure 3A,B,E). When observed using SEM, these vesicles appear smooth and appear to be detached from the surrounding cellular structures

• images revealed vesicles (ve) inside the cells. These either exhibited substantial staining intensity due to the applied staining methods or displayed an orange coloration without staining (Figure 5A,B,E). Upon examination through SEM, they appeared spherical and presented either a smooth or slightly

• of both attachment pads show multiple morphological similarities. Both exocrine cells display comparable staining patterns with toluidine blue and Cason. They possess a sizable nucleus containing numerous nucleoli, a substantial abundance of vesicles and hollow spaces, the absence of a discernible

Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent

• Horacio Emanuel Jerez,
• Yamila Roxana Simioni,
• Kajal Ghosal,
• Maria Jose Morilla and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 517–534, doi:10.3762/bjnano.15.46

• types respond to LPS stimulation with more irritation; FCs are known to facilitate pathogenesis by producing eicosanoids, tissue-damaging enzymes, and extracellular vesicles [86]. The resultant responses diffused either downwards or upwards across the porous membrane, constituting what we called a

Nanomedicines against Chagas disease: a critical review

• Maria Jose Morilla,
• Kajal Ghosal and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 333–349, doi:10.3762/bjnano.15.30

• remaining nearly 45% are lipid-based nanoparticles, constituting the most prevalent category of nanomedicines accessible in the market [91]. These include uni- or multilamellar liposomes (vesicles formed by bilayers of amphiphilic lipids), and lipid nanoparticles. The introduction of new preparation

• expensive, enterprise. Much more expensive and riskier will be developing nanomedicines for the delivery of non-approved molecules. In 2021, the effect of a subcutaneous immunostimulant with imiquimod loaded in nanoarchaeosomes (a type of lipid vesicles, nanoarc-imq) on an acute model of CD was reported

Ferromagnetic resonance spectra of linear magnetosome chains

• Elizaveta M. Gubanova and
• Nikolai A. Usov

Beilstein J. Nanotechnol. 2024, 15, 157–167, doi:10.3762/bjnano.15.15

• along the chain axis. In contrast, it was shown [39] that the formation of magnetosomes in a bacterium can occur simultaneously in many germ vesicles along its length. In this case, it is not clear what reason can lead to the occurrence of E-type anisotropy in the chain. Rather, one would expect a

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• ]. Although this nanostructured system is a promising carrier, further in vitro and in vivo studies are necessary to evaluate such improvements for curc or other leishmanicidal drugs. Nanoliposomes Nanoliposomes are nanoscale lipid bilayer vesicles mainly composed of phospholipids. These systems (small

• nanoliposomes promoting increased antiparasitic activity. Recently, Bafghi and collaborators produced nanoliposomes for curc delivery as a new alternative for leishmaniasis treatment [89]. Briefly, the nanoliposomes were prepared by thin-film hydration, resulting in spherical vesicles with 176.5 nm of diameter

Nanotechnological approaches in the treatment of schistosomiasis: an overview

• Lucas Carvalho,
• Michelle Sarcinelli and
• Beatriz Patrício

Beilstein J. Nanotechnol. 2024, 15, 13–25, doi:10.3762/bjnano.15.2

• homogenization); (2) low-energy methods, which requires the precipitation of nanoparticles from homogeneous systems (such as microemulsions); and (3) methods based on organic solvents (emulsification–diffusion method) [35]. Liposomes are vesicles composed of a phospholipid and cholesterol with an aqueous core

Elasticity, an often-overseen parameter in the development of nanoscale drug delivery systems

• Agnes-Valencia Weiss and
• Marc Schneider

Beilstein J. Nanotechnol. 2023, 14, 1149–1156, doi:10.3762/bjnano.14.95

• with a model hydrogel that there is a higher penetration for more deformable extracellular vesicles from mouse mesenchymal stromal cells [37]. A second study, from Yu et al., shows rigidity-dependent penetration of lipid NPs in the mucus layer of rat intestinal mucus. Liposomes were either hollow or

Green SPIONs as a novel highly selective treatment for leishmaniasis: an in vitro study against Leishmania amazonensis intracellular amastigotes

• Brunno R. F. Verçoza,
• Robson R. Bernardo,
• Luiz Augusto S. de Oliveira and
• Juliany C. F. Rodrigues

Beilstein J. Nanotechnol. 2023, 14, 893–903, doi:10.3762/bjnano.14.73

• ultrastructural changes were observed in intracellular amastigotes: (1) many lipid bodies (A–C, thin arrows), (2) increased secretion of extracellular vesicles (A–C, broad arrows), (3) intracellular vacuolization (A–C, arrows), (4) myelin-like figures (A, arrowhead), (5) mitochondrial swelling (C, star), and (6

The steep road to nonviral nanomedicines: Frequent challenges and culprits in designing nanoparticles for gene therapy

• Yao Yao,
• Yeongun Ko,
• Grant Grasman,
• Jeffery E. Raymond and
• Joerg Lahann

Beilstein J. Nanotechnol. 2023, 14, 351–361, doi:10.3762/bjnano.14.30

• measurement. For NTA, ASTM 2834 provides workflows for planning NP experiments. Through the study of nanoscale extracellular vesicles, Bachurski et al. [68] provide some additional insights comparing the performance of different NTA systems to cryo-TEM and single-particle interferometric reflectance imaging

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• membranes have been exploited for the development of novel membrane NP-based therapies, such as erythrocytes [10], platelets [11], cancer cells [14], stem cells [12], immune cells [13], central nervous system-derived cells [17], bacterial outer membrane vesicles [18], and extracellular vesicles [19]. Cancer

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

• Filip Gorachinov,
• Fatima Mraiche,
• Diala Alhaj Moustafa,
• Ola Hishari,
• Yomna Ismail,
• Jensa Joseph,
• Maja Simonoska Crcarevska,
• Marija Glavas Dodov,
• Nikola Geskovski and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2023, 14, 240–261, doi:10.3762/bjnano.14.23

• surface, triggered by protease degradation after tumor homing by the EPR effect [112]. Mesoporous silica vesicles (MSVs; dav = 3 μm) with high affinity to tumor vasculature were also described by Blanco et al. as a platform for the triggered release of various therapeutic nanoscale vectors (liposomes

Ethosomal (−)-epigallocatechin-3-gallate as a novel approach to enhance antioxidant, anti-collagenase and anti-elastase effects

• Çiğdem Yücel,
• Gökçe Şeker Karatoprak,
• Sena Yalçıntaş and
• Tuğba Eren Böncü

Beilstein J. Nanotechnol. 2022, 13, 491–502, doi:10.3762/bjnano.13.41

•  2). El Kayal et al. conducted a study that provided the basis for the development of formulations as ETHs, transfersomes, and transethosomes to maximize the therapeutic efficacy of EGCG. The formulation compositions were optimized to produce vesicles with acceptable physical properties for these

• liposomes, which have limited skin penetration and mostly remain in the upper layer of the stratum corneum. The release of the therapeutic agent occurs by the fusion of these vesicles with the cell membranes in the deeper layers of the skin [11]. ETHs have been reported to help many active substances to be

• min followed by sonication using an ultrasonic bath (Wise Clean, Korea, 210 W, 40 kHz), at 40% sonication strength, and three cycles of 30 min to obtain monodisperse vesicles and to enhance encapsulation efficiency [44][45]. Then, ETHs were collected by centrifugation at 10.000 rpm for 30 min. For the

pH-driven enhancement of anti-tubercular drug loading on iron oxide nanoparticles for drug delivery in macrophages

• Karishma Berta Cotta,
• Sarika Mehra and
• Rajdip Bandyopadhyaya

Beilstein J. Nanotechnol. 2021, 12, 1127–1139, doi:10.3762/bjnano.12.84

• Intracellular pathogens are often contained in vesicles within phagocytic cells like the macrophages. These vesicles are known to present an acidic environment [42], while the normal physiological pH of the cell remains neutral [43]. Thus, nanoparticles used in drug delivery to macrophages would experience both

Use of nanosystems to improve the anticancer effects of curcumin

• Andrea M. Araya-Sibaja,
• Norma J. Salazar-López,
• Krissia Wilhelm Romero,
• José R. Vega-Baudrit,
• J. Abraham Domínguez-Avila,
• Carlos A. Velázquez Contreras,
• Ramón E. Robles-Zepeda,
• Mirtha Navarro-Hoyos and
• Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

• . Liposomes are one of the most well-studied nanosystems. They are self-assembled vesicles with at least one phospholipid bilayer with a diameter size in the range of 50–450 nm when used for medical purposes, and are often used to deliver both hydrophilic and hydrophobic molecules [71][72]. Their main

The role of convolutional neural networks in scanning probe microscopy: a review

• Ido Azuri,
• Irit Rosenhek-Goldian,
• Neta Regev-Rudzki,
• Georg Fantner and
• Sidney R. Cohen

Beilstein J. Nanotechnol. 2021, 12, 878–901, doi:10.3762/bjnano.12.66

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

• on triggering exocytosis leading to the release of extracellular vesicles [187]. Microbubbles were first developed as contrast agents and then were used in cargo delivery. Nowadays, they play a role as theranostic agents [178][188]. Many studies have shown that the concurrent use of MBs and US